AstraZeneca strikes deal with Oxford University to mass produce experimental COVID-19 vaccine

Human trials of the ChAdOx1 nCoV-19 vaccine developed by Oxford University's Jenner Institute began last week, with hundreds of people volunteering to be part of the study.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news